- June 2, 2018
- Posted by: admin
- Category: Updates
No Comments
Burosumab, a monoclonal antibody against FGF23, was found To Improve Rickets Severity In Children With X-Linked Hypophosphatemia.
Burosumab, a monoclonal antibody against FGF23, was found To Improve Rickets Severity In Children With X-Linked Hypophosphatemia.